Effective Prophylactic Therapy for Exposure to Monkey B Virus (Macacine alphaherpesvirus 1).

Abstract

Zoonotic monkey B virus (Macacine alphaherpesvirus 1; BV) infections are extremely serious and usually fatal. Drugs currently used for treatment were developed for the treatment of herpes simplex virus but are less effective against BV. Effective suppression of viral replication in the skin could prevent the virus from invading the nervous system. To test this hypothesis, the efficacy of topical administration of several drugs against lethal BV infection was evaluated in female BALB/c mice that were infected by scarification. Drugs were then applied to the site of inoculation. As 3% preparations, most drugs were only minimally effective or ineffective. In contrast, ganciclovir and cidofovir were very effective. The ED50 for cidofovir was 0.007%, compared with 1.1% for ganciclovir. At 0.5%, cidofovir protected against both death and neurologic signs, whereas 5% ganciclovir only protected against death but not neurologic involvement. All genotypes of BV were equally susceptible to cidofovir and ganciclovir. For maximal effectiveness, treatment with both cidofovir and ganciclovir had to be initiated within 8 h of infection. Cidofovir was completely protective when administered only on the day of infection, whereas a minimum of 5 d of treatment was required for maximal ganciclovir efficacy. These studies showed that topical cidofovir treatment started soon after BV exposure was very effective in preventing BV from invading the nervous system, whereas ganciclovir treatment was only partially effective. In addition, cidofovir was protective against a ganciclovir-resistant BV mutant, whereas ganciclovir was not. These studies showed that topical cidofovir treatment started soon after BV exposure is more effective than ganciclovir in preventing BV from invading the CNS.

• Authors: Lara K Maxwell, Darla H Black, George E Wright, Melanie A Breshears, Richard Eberle
• Journal: Comparative medicine (Comp Med) Vol. 70 Issue 1 Pg. 56-66 (02 01 2020) ISSN: 2769-819X [Electronic] United States
• PMID: 31810502 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Antiviral Agents
• Cidofovir
• Ganciclovir

Topics

• Animals
• Antiviral Agents (pharmacology)
• Cidofovir (pharmacology)
• Disease Models, Animal
• Female
• Ganciclovir (pharmacology)
• Herpesviridae Infections (prevention & control)
• Herpesvirus 1, Cercopithecine (drug effects)
• Humans
• Mice
• Mice, Inbred BALB C
• Pre-Exposure Prophylaxis
• Skin Diseases, Viral (pathology, prevention & control)